Skip to content

Gross margin at other companies

IAR
Integra LifeSciencesIART
51.9%-1.6pp
MiMedx Group logo
MiMedx GroupMDXG
81%-0.9pp
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
75.9%+0.8pp
Solventum logo
SolventumSOLV
53.7%-0.9pp
The Beauty Health Company logo
The Beauty Health CompanySKIN
64.9%+8.3pp
ClearPoint Neuro logo
ClearPoint NeuroCLPT
62.3%+1.1pp

Other financials

Income statement

See full
Revenue$9.6M+3.1%
Gross profit$7.4M+0.8%
Operating income-$1.1M-287%
Net income-$1.4M+76.5%
EPS (diluted)-$0.17+76.4%

Balance sheet

See full
Cash & equivalents$10.8M+26.8%
Total debt$21.7M+5,319%
Total equity$1.8M+109%
Total assets$37.1M+20.2%

Cash flow

See full
Operating cash flow$397.0K+126%
CapEx$23.0K-85.8%
Free cash flow$374.0K+122%

Valuation

See full
Market cap$85.99M+10.0%
Enterprise value$96.88M
P/E5.2×
P/S1.9×

Profitability

See full
Operating margin7.3%-8.6pp
Net margin37.2%+21.6pp
FCF margin9%

Returns & leverage

See full
Return on equity-173.8%
Debt / equity11.8×
Current ratio1.3×+0.9×

Where this comes from

Calculated from SANUWAVE Health, Inc.’s reported figures.

Based on trailing twelve months.

The official record: SANUWAVE Health, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SANUWAVE Health, Inc.'s gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s gross margin?
SANUWAVE Health, Inc. (SNWV) reported gross margin of 76.7% in Q1 2026.
How has SANUWAVE Health, Inc.'s gross margin changed year-over-year?
SANUWAVE Health, Inc.'s gross margin increased by 0.2% year-over-year, from 76.6% to 76.7%.
What is the long-term trend for SANUWAVE Health, Inc.'s gross margin?
Over 4 years (2021 to 2025), SANUWAVE Health, Inc.'s gross margin has grown at a 5.7% compound annual growth rate (CAGR), from 61.7% to 77.1%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.